---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-187636"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:41:40.432127+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Viridian posts updated investor presentation on website; contents not detailed in filing

## Summary
- Presentation dated July 2023 titled 'Corporate Overview' made available via 8-K.
- No financial results, pipeline milestones, or guidance revisions disclosed in the filing excerpt.
- Company stated presentation was posted under Regulation FD; no material new facts provided.

## SEC filing metadata
- accession: 0001193125-23-187636
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312523187636/0001193125-23-187636-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312523187636/d530903d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-187636
- JSON: https://secwatch.observer/filing/0001193125-23-187636.json
- Plain text: https://secwatch.observer/filing/0001193125-23-187636.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.